Cookies on the
LGC website
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on the LGC website. However, if you would like to, you can change your cookie settings at anytime.
Question markFind out more

18 Dec LGC reports half year trading in line with expectations

Update for the half year ended 30 September 2018

15 Nov Scientists set to overhaul International System of Units

Decision will assure future stability of SI

08 Oct LGC ranks 54 in Sunday Times’ business standings

The 2018 ranking is an improvement on last year’s rank of 63

01 Oct LGC invests in new GMP analytical capability

Significant investment at Kulmbach site expands capacity of specialist therapeutic oligonucleotide development solutions business

27 Sep LGC acquires Berry & Associates

Investment follows other acquisitions in oligonucleotide reagent and synthesised oligonucleotides markets